 Juan Monteverde, founder and managing partner at Monteverde Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Cellular Biomedicine Group, Inc. CBMG or the Company Nasdaq: CBMG relating to its sale to a consortium that includes members of CBMG management and several entities. Under the terms of the agreement, CBMG shareholders will receive 19.75 in cash for each share of CBMG stock they own. 